To evaluate the trends in amputation rates among opioid-related hospitalizations compared to nonopioid-related hospitalizations from 2016 to 2022.
Key Findings:
Amputation rates among opioid-related hospitalizations increased from 56 to 92 per 10,000 hospitalizations from 2016 to 2022.
Nonopioid-related hospitalizations saw an increase from 59 to 80 per 10,000 hospitalizations.
Amputations occurred in fewer than 1% of opioid-related hospitalizations in 2022.
The increase in amputation rates was 13 additional amputations per 10,000 hospitalizations greater for opioid-related cases.
Opioid-related hospitalizations had a higher proportion of upper-extremity amputations and higher anatomical level amputations.
Interpretation:
The study indicates a concerning trend of rising amputation rates among opioid-related hospitalizations, potentially linked to factors such as increased injection frequency and infections.
Limitations:
Serial cross-sectional design limits causal inference.
Use of administrative coding may introduce inaccuracies.
Inability to directly link opioid use to amputation outcomes.
Potential residual confounding from unmeasured clinical or behavioral risk factors.
Conclusion:
Amputation rates have increased more significantly among opioid-related hospitalizations compared to nonopioid-related ones, particularly in certain regions.
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.